Rayont Inc (RAYT) Return on Equity ROE from the third quarter 2023 to third quarter 2022 and annually, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rayont Inc   (RAYT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Rayont Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Rayont Inc in the third quarter 2023?
Rayont Inc achieved a return on average equity (ROE) of 12.07 % in its third quarter 2023, this is above RAYT's average return on equity of -39.86%.
Rayont Inc shareholder's equity over the 12 months ending in its third quarter 2023 are valued at $6 million

ROE fell compared to the second quarter 2023, despite the net income growth of % from the second quarter 2023.

Within the Healthcare Facilities industry 6 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2023 from 617 to 1280.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter		 (Sep 30 2022)
I. Quarter		 (Jun 30 2022)
IV. Quarter		 (Mar 31 2022)
III. Quarter
Y / Y Equity Change 29.74 % 43.47 % 38.5 % 36.67 % -
Y / Y Net Income Change - - - - -43.67 %
Net Income (TTM) in Millions 1 1 1 0 -1
Return On Equity (TTM) 12.07 % 19.11 % 19.97 % 5.28 % -17.7 %
RAYT's Total Ranking # 1280 # 617 # 772 # 0 # 0
Equity (TTM) in Millions 6 6 6 5 5
Seq. Equity Change -5.26 % -1 % 23.72 % 11.8 % 4.77 %
Seq. Net Income Change - - -35.65 % 866.4 % -

Back to RAYT Management Effectiveness >> RAYT's 5 Years Annual ROE >> Compare RAYT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 7
Sector # 98
Overall # 1280

Return On Equity Statistics
High Average Low
19.97 %
-39.86 %
-475.8 %
(Sep 30 2022)   (Dec 31 2017)





RAYT Annual Return On Equity (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018
Total Equity in Millions 5 4 1 1 0
Y / Y Equity Change 36.67 % 304 % -6.45 % - -
Net Income in Millions 0 0 0 -1 0
Y / Y Net Income Change -36.22 % - - - -
Return On Equity 4.81 % 10.3 % -24.87 % -128.04 % -

Back to RAYT Management Effectiveness >> RAYT's 5 Years Annual ROE >> Compare RAYT ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 4.81 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RAYT's' Return on Equity at Yahoo Finance
RAYT's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RAYT's Competitors
Subscribers only: Roe for Rayont Inc 's Suppliers
Subscribers only: Return On Equity for RAYT's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE
Chemed Corporation  31.06 %
Pfizer Inc  30.83 %
Bruker Corporation  29.49 %
Ironwood Pharmaceuticals inc   29.31 %
Semler Scientific inc   28.98 %
Merck and Co Inc   28.84 %
Carlisle Companies Incorporated  27.74 %
Oncotelic Therapeutics Inc   27.58 %
Pro dex Inc   26.83 %
Gilead Sciences Inc   26.56 %
Point Biopharma Global Inc   26.47 %
Zynex inc   26.02 %
Moderna Inc   25.87 %
Agilent Technologies inc   25.16 %
Edwards Lifesciences Corporation  24.78 %
Resmed Inc   24.50 %
Vertex Pharmaceuticals Inc  24.46 %
Biogen Inc   24.17 %
Bristol myers Squibb Company  22.83 %
Puma Biotechnology Inc   21.52 %
West Pharmaceutical Services Inc   21.32 %
Escalon Medical Corp   21.09 %
Siga Technologies Inc  20.68 %
Ufp Technologies Inc   20.35 %
Exicure Inc   20.13 %
Iradimed Corporation  20.09 %
Precigen Inc   19.53 %
Dr Reddy s Laboratories Limited  19.50 %
Corcept Therapeutics Inc  19.37 %
Patterson Companies Inc   19.26 %

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.